161 related articles for article (PubMed ID: 12206035)
1. Primary multi-drug resistant tuberculous gumma.
Sharma N; Kumar P; Mantoo S; Patnaik S
J Commun Dis; 2001 Sep; 33(3):170-3. PubMed ID: 12206035
[TBL] [Abstract][Full Text] [Related]
2. [Therapy-resistant tuberculous skin abscesses after methylprednisolone therapy].
Daxecker M; Weiss G
Dtsch Med Wochenschr; 2008 Feb; 133(8):346-9. PubMed ID: 18270914
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous extensively drug-resistant tuberculosis.
Olson DP; Day CL; Magula NP; Sahid F; Moosa MY
Am J Trop Med Hyg; 2007 Sep; 77(3):551-4. PubMed ID: 17827377
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the radiometric BACTEC 460 TB culture system and Löwenstein-Jensen medium for the isolation of mycobacteria in cutaneous tuberculosis and their drug susceptibility pattern.
Aggarwal P; Singal A; Bhattacharya SN; Mishra K
Int J Dermatol; 2008 Jul; 47(7):681-7. PubMed ID: 18613873
[TBL] [Abstract][Full Text] [Related]
7. Tuberculous gumma in a patient with cervical lymphadenitis.
Difonzo EM; Lotti L; Salvini C; Sestini S; Fabroni C
Int J Dermatol; 2006 Dec; 45(12):1467-8. PubMed ID: 17184269
[No Abstract] [Full Text] [Related]
8. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
9. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
Matee M; Mfinanga S; Holm-Hansen C
APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
[TBL] [Abstract][Full Text] [Related]
10. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for drug resistant tuberculosis in southeast Turkey.
Tanrikulu AC; Hosoglu S; Ozekinci T; Abakay A; Gurkan F
Trop Doct; 2008 Apr; 38(2):91-3. PubMed ID: 18453496
[TBL] [Abstract][Full Text] [Related]
12. Multiple Mycobacterium tuberculosis infections in an HIV-infected patient.
van der Zanden AG; Rahim Z; Fedder G; Vos-van Adrichem J; Sebens FW; Heilmann FG; van Soolingen D
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):704-5. PubMed ID: 17883010
[TBL] [Abstract][Full Text] [Related]
13. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.
Sacchettini JC; Rubin EJ; Freundlich JS
Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742
[TBL] [Abstract][Full Text] [Related]
14. [Management of TB suspected cases of drug resistant tuberculosis requiring a second treatment].
Caminero JA
Biomedica; 2004 Jun; 24 Supp 1():212-27. PubMed ID: 15495588
[TBL] [Abstract][Full Text] [Related]
15. Extensively drug-resistant tuberculosis: current challenges and threats.
Jain A; Mondal R
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
17. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
18. Drug susceptibility profiling of tuberculous meningitis.
Nagarathna S; Rafi W; Veenakumari HB; Mani R; Satishchandra P; Chandramuki A
Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
[TBL] [Abstract][Full Text] [Related]
19. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
[TBL] [Abstract][Full Text] [Related]
20. Drug-resistant tuberculosis in Cuba. Results of the three global projects.
Montoro E; Lemus D; Echemendía M; Armas L; González-Ochoa E; Llanes MJ; Valdivia JA
Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
